Mervi Salmela

Mervi Salmela serves as CEO at Vitabalans Oy. Vitabalans Oy operates in the pharmaceuticals sector with approximately 120.0 employees. The company is headquartered in Lempaeaelae. Vitabalans Oy generates annual revenue of 22200000.0.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • Our database includes 201,469 c suite-level executives.

Cloudflare DNS Outlook Microsoft Office 365 CloudFlare Hosting Google Dynamic Remarketing Google Tag Manager DoubleClick Mobile Friendly Google Font API Facebook Widget WordPress.org Facebook Login (Connect) Disqus Woo Commerce Facebook Custom Audiences Vimeo DoubleClick Conversion Render

pharmaceuticals medicines food supplements oct pom medical devices animal health pharmaceutical manufacturing prescription medicines otc medicines melatonin diabetes management antidepressants pain relief antibiotics allergy medications cardiac medications cardiovascular health insomnia solutions folic acid supplements self-care products vitality aids gels for wound treatment veterinary products dog care cat supplements horse nutrition mineral supplements trace elements intimate care products immune system support glucosamine for joints hair & nail health skin health cough remedies sore throat relief fever reducers vitamins a to e multivitamins fluid balance lactic acid bacteria performance recovery supplements hydrocolloid dressings homeopathy nutritional supplements hygiene products healthy lifestyle export pharmaceuticals veterinary nutrition infant care products antihistamines topical analgesics children's health elderly care chronic disease management health supplements medical hospital & health care

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Mervi Salmela in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Vitabalans Oy.

Mervi Salmela's Position in the MessageCEO Database

• •Mervi Salmela is 1 of 1 verified executive contact we track at Vitabalans Oy.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •35 verified contacts work at pharmaceuticals companies in the 120.0 employee range (same size as Vitabalans Oy).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Mervi Salmela directly?

Mervi Salmela's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Vitabalans Oy. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Mervi Salmela work for?

Mervi Salmela is CEO at Vitabalans Oy, a company in the pharmaceuticals sector with 120.0 employees. The company is based in Lempaeaelae.

Can I pitch or sell to Mervi Salmela?

As CEO at Vitabalans Oy, Mervi Salmela is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Mervi Salmela directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Mervi Salmela in?

Mervi Salmela works in the pharmaceuticals industry as CEO at Vitabalans Oy. MessageCEO provides verified contact information for executives across all major industries.

Is Mervi Salmela's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Mervi Salmela's profile is kept up-to-date with the latest available information.

Last updated: June 21, 2026